Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
541 to 560 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| U01HL145547 | Immunobiology and alveolar physiology of the aging lung | 1 | 2022 |
| U19AI135976 | Omics for TB: Response to Infection and Treatment | 1 | 2022 |
| U54CA232568 | Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers | 1 | 2022 |
| ZIAAI001152 | Integrative analysis and modeling of human immune responses and pathologies | 1 | 2022 |
| R01AI081848 | Exposing virus-induced long noncoding RNA in plasmacytoid dendritic cells | 9 | 2021 |
| R01CA206890 | Imaging tumor associated macrophage (TAM) function | 5 | 2021 |
| U01CA206997 | Imaging of nanotherapeutic drug action | 3 | 2021 |
| F32MH122058 | Decoding the Sex-Specific Biological Mechanisms of Psychiatric Disorders Using Genome-Wide Analyses | 2 | 2021 |
| IK6BX003615 | BLR&D Research Career Scientist Award Application | 2 | 2021 |
| R01GM123126 | Enhancing the International Molecular Exchange (IMEx): Providing an Improved Community-Oriented Molecular Interactions Resource | 2 | 2021 |
| R01MH113362 | Discovering Biology for Neuropsychiatric Diseases Through Omics Studies on Comorbidities | 2 | 2021 |
| R21DC018098 | Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking Behaviors | 2 | 2021 |
| R24OD024622 | Biorepository of iPSC lines from diverse rat strains for regenerative medicine research | 2 | 2021 |
| U01CA224348 | Reprogramming PDAC tumor microenvironment to improve immunotherapy | 2 | 2021 |
| U19AI100625 | Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross | 2 | 2021 |
| U41HG003751 | Reactome: An Open Knowledgebase of Human Pathways | 2 | 2021 |
| DP5OD024576 | Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination | 1 | 2021 |
| F30AI154740 | The role of meningeal lymphatic vasculature in regulating immunity and intracranial pressure during central nervous system infection | 1 | 2021 |
| F30CA228315 | Molecular targeted radiotherapy to overcome resistance to in situ cancer vaccination | 1 | 2021 |
| F30CA236454 | Autochthonous and Ex-vivo Derived Mouse Models of Malignant Glioma | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=28